Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:06:42.774Z.
Calculation as of: 2026-10-06T17:06:42.774Z.
Quote observation: 2026-10-06T17:05:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e7bb4fe4bb3aa983eb4620adc8aa5d0f555a5020ff21ce65ee2b72f9631e0f85
EARNINGS YIELD
N/A
Market Cap
$2.81B
Earnings Yield
4.75%
TTM Avg
3.82%
3Y Avg
2.33%
5Y Avg
2.33%
Market Cap
$2.67B
Earnings Yield
10.30%
TTM Avg
9.07%
3Y Avg
6.61%
5Y Avg
6.61%
Market Cap
$2.67B
Earnings Yield
N/A
TTM Avg
8.33%
3Y Avg
6.72%
5Y Avg
5.70%
Market Cap
$2.67B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.83B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 4.75% | 3.82% | 2.33% | 2.33% |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 0.39% | 0.43% | 0.43% | 1.84% |
| Precigen, Inc. (PGEN)vs › | $2.71B | N/A | 7.93% | 7.93% | 7.93% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.67B | 10.30% | 9.07% | 6.61% | 6.61% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.67B | N/A | 8.33% | 6.72% | 5.70% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.67B | N/A | N/A | N/A | N/A |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.00B | N/A | N/A | N/A | N/A |
| Neogen Corporation (NEOG)vs › | $2.66B | N/A | 0.18% | 1.09% | 1.28% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.02B | 0.86% | 0.82% | 0.82% | 0.82% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
